New England Biolabs said last week that it will supply next-generation sequencing library construction reagents to the Wellcome Trust Sanger Institute.
New England Biolabs, based in Ipswich, Mass., will supply the Sanger Institute with NEBNext DNA Sample Prep Reagent Sets, which contain enzymes and buffers that are suited for preparing next-generation sequencing samples and expression libraries.
Reagents are available for each step of library construction workflow and are compatible with the Illumina GAII, Roche/454 GS FLX Titanium, and Life Technologies SOLiD 3 platforms.
"We are extremely pleased that the Wellcome Trust Sanger Institute, as a world-leading genome center, has determined that our reagents meet their high standards," Peter Nathan, director of global business development at New England Biolabs, said in a statement.